# Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke

Study · id `cardio:ct-nct03661411` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03661411](<https://clinicaltrials.gov/study/NCT03661411>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03661411

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 760 participants.

## Technical summary

Registry record NCT03661411. Randomized; no masking; primary purpose treatment. Start 2018-10-17 (actual); primary completion 2022-07-18 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 760 participants (enrolled count; ClinicalTrials.gov record NCT03661411, source copy `cardio:ctgov-nct03661411-2022-08-03`, retrieved 2026-10-26)
- Started: 2018-10-17 (actual) (ClinicalTrials.gov record NCT03661411, source copy `cardio:ctgov-nct03661411-2022-08-03`, retrieved 2026-10-26)
- Primary completion: 2022-07-18 (actual) (ClinicalTrials.gov record NCT03661411, source copy `cardio:ctgov-nct03661411-2022-08-03`, retrieved 2026-10-26)
- Completion: 2022-07-18 (actual) (ClinicalTrials.gov record NCT03661411, source copy `cardio:ctgov-nct03661411-2022-08-03`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03661411, source copy `cardio:ctgov-nct03661411-2022-08-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03661411-2022-08-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke
- Acronym: ARAMIS
- Condition: Stroke
- Intervention (Drug): Aspirin
- Intervention (Drug): Clopidogrel 75mg
- Intervention (Drug): Alteplase
- Lead sponsor: General Hospital of Shenyang Military Region
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry lists this organization as the lead sponsor: General Hospital of Shenyang Military Region (`cardio:org-general-hospital-of-shenyang-military-region`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial (`cardio:pubmed-37367978`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Systolic blood pressure and early neurological deterioration in minor stroke: A post hoc analysis of ARAMIS trial (`cardio:pubmed-39014552`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Dual Antiplatelet Versus Alteplase for Early Neurologic Deterioration in Minor Stroke With Versus Without Large Vessel Occlusion: Prespecified Post Hoc Analysis of the ARAMIS Trial (`cardio:pubmed-39387110`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Dual Antiplatelet Therapy Versus Alteplase for Mild Stroke with Admission NIHSS Score 0-3 Versus 4-5: A Secondary Analysis of the ARAMIS Randomized Trial (`cardio:pubmed-40760234`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Onset to Treatment Time and Early Neurological Deterioration of Dual Antiplatelet Therapy Versus Alteplase in Minor Stroke (`cardio:pubmed-41128284`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 094a152342f1e6e6847db22982abeb690811a1407a972ed2db2d3d8fa60392a2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
